Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

September 24, 2024

5 life sciences companies expanding in CT

Contributed Several companies are occupying space in the new life sciences tower at 101 College St., New Haven.
By Hanna Snyder Gambini

Five bioscience companies are expanding their operations in Connecticut, including several that are leasing space in the new life sciences building at 101 College St., in New Haven, according to AdvanceCT, a nonprofit business recruitment agency.

Cellsbin is a venture capital-backed startup that makes oncology-detection medical devices. It was founded by a team of industry experts in the fields of photonics, molecular biology and artificial intelligence. The company has signed a lease at BioLabs’ collaborative laboratory and coworking space at 101 College St.

Cellsbin is expanding its research and development efforts, investing roughly $1 million and adding five members to its staff, according to AdvanceCT.

EpiTET Therapeutics is a Yale University spinout that combines AI-enabled patient selection with targeted therapeutics to tame inflammation in endometriosis and solid cancers. The company set up its first office at The District coworking space on James Street in New Haven, adding 10 jobs and investing $8 million in the state as it continues through its pre-clinical and fundraising efforts, according to AdvanceCT.

NanomediGene is a biotechnology research and development company specializing in nanotechnology and targeted drug delivery systems of proteins, drug molecules, genes and cellular-based therapies. The company is expanding into Connecticut after securing a partnership with Yale University, working out of the Biolabs space. 

NanomediGene will create 10 jobs for its Connecticut operations and invest more than $3 million in the new lab space, according to AdvanceCT.

Oxylus Energy, another Yale University spinout, is a green-energy company working toward net-zero carbon emissions through the conversion of CO2 into carbon-neutral fuels and chemicals via electrolyzer technology. It will set up offices in Branford. 

Oxylus will add six jobs and invest $4.5 million in the town after leveraging investment from Connecticut Innovations’ ClimateTech Fund, according to AdvanceCT.

Talam Biotech, an agricultural R&D company developing technology that reduces heavy metals in food crops using microbes, relocated its headquarters and facility to BioCT's Innovation Commons life sciences incubator space in Groton. 

Formerly based in Dublin, Ireland, the company relocated to Connecticut due to the opportunities for partnerships within the state’s biotech cluster, according to AdvanceCT.
 

Sign up for Enews

Most Recent

Most Recent

0 Comments

Order a PDF